Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Westendorf, Astrid M.
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (TR60, GRK1949)